|
NTRA
|
Natera, Inc.
|
0.34%
|
US
|
NASDAQ
|
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
0.33%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
0.33%
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
0.32%
|
US
|
NASDAQ
|
|
ZLAB
|
Zai Lab Limited
|
0.31%
|
US
|
NASDAQ
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
0.30%
|
US
|
NASDAQ
|
|
TXG
|
10x Genomics, Inc.
|
0.30%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
0.28%
|
US
|
NASDAQ
|
|
PTCT
|
PTC Therapeutics, Inc.
|
0.26%
|
US
|
NASDAQ
|
|
PCVX
|
Vaxcyte, Inc.
|
0.26%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
0.26%
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
0.26%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
0.26%
|
US
|
NASDAQ
|
|
ABCM
|
Abcam plc
|
0.25%
|
US
|
NASDAQ
|
|
ISEE
|
IVERIC bio, Inc.
|
0.24%
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
0.23%
|
US
|
NASDAQ
|
|
INSM
|
Insmed, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
0.22%
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
0.22%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
0.22%
|
US
|
NASDAQ
|